INTRODUCTION
Endothelial cells play an important role in the control of thrombosis and haemostasis on the membrane. Protein C, a vitamin K-dependent zymogen, is converted into its active form by thrombin and the activated Protein C serves as an anticoagulant by inactivation of Factors Va and Vllla by limited proteolytic cleavage [1] [2] [3] . Thrombomodulin, a glycoprotein on the endothelial cell surface, is a high-affinity receptor for thrombin, and the thrombin-thrombomodulin complex shows potent anticoagulant properties through marked acceleration of Protein C activation compared with that produced by thrombin alone [4] [5] [6] [7] . Expression of thrombomodulin on the surface of endothelial cells is increased by treatment with dibutyryl cyclic AMP [8, 9] or retinoic acid [10, 11] , and is decreased by exposure to tumour necrosis factor a [11] [12] [13] or interleukin 1? [9] .
Thrombin-and Protein C-binding sites of thrombomodulin have been examined and it has been shown that thrombin and Protein C bind to the fifth [14] and fourth [15, 16] epidermal growth factor-like structures respectively of thrombomodulin. Preissner et al. [17] suggested that a secondary thrombin-binding site possibly exists on the acidic domain of thrombomodulin, a sulphated glycosaminoglycan. However, no particular attention constituted into dilinolenoyl PtdEtn/distearoyl PtdCho was 14.6 times that by thrombomodulin reconstituted into distearoyl PtdEtn/distearoyl PtdCho, as a result of a decrease in the dissociation constant (Kd) for thrombin and the Michaelis constant (Km) for Protein C of thrombomodulin. Binding of Protein C to PtdEtn/PtdCho fixed to a microwell plate required the presence of CaCl2 and increased with increasing degree of unsaturation of fatty acid in PtdEtn. As PtdEtn appeared on the outside of the plasma membrane in cultured human umbilical vein endothelial cells after thrombin stimulation, it was presumed that Protein C activation could be elevated by PtdEtn at the outer surface of the plasma membrane via an increased affinity between thrombomodulin, thrombin and Protein C, resulting from both increased formation of the thrombinthrombomodulin complex via a conformational change in thrombomodulin and increased binding of Protein C to the membrane phospholipid in a Ca2+-dependent manner.
was paid in these studies to the influence of the phospholipid-rich environment of the endothelial cell surface.
In 1982, Esmon et al. [18] purified thrombomodulin from rabbit lung and first described the apparent inconsistency between its cofactor activity and its activity on endothelial cells. They suggested that the decrease in thrombin-dependent Protein C activation by thrombomodulin might be due to loss of phospholipids during the purification procedure [18] . Freyssinet et al. [19] reconstituted thrombomodulin into phospholipid vesicles, and suggested that anionic phospholipids might be of functional significance in the activation of Protein C by the thrombinthrombomodulin complex. They proposed that the positive effect involved a Ca2l-dependent interaction between Protein C and phospholipids. On the other hand, Galvin et al. [20] suggested that the increase in Protein C activation caused by reconstituted thrombomodulin might involve a Ca2+-dependent interaction between Protein C and thrombomodulin, which exposes a Protein C-binding site after conformational change that results from its interaction with phospholipids. Thus Protein C activation on endothelial-cell membrane is controlled not only by the amount of thrombomodulin expressed but also by changes in the membrane environment, such as phospholipid composition. In order to clarify further the physiological control mechanism of thrombin-dependent Protein C activation by thrombomodulin (cofactor activity of thrombomodulin) on the endothelial cell surface, which is rich in phospholipids containing unsaturated fatty acid [21] , we investigated the effect of the composition of phospholipid vesicles on this cofactor activity.
In the present study, we reconstituted human placental thrombomodulin into phosphatidylethanolamine (PtdEtn) and phosphatidylcholine (PtdCho) vesicles, which exhibited the largest increase in thrombin-thrombomodulin-catalysed Protein C activation among various phospholipid vesicles tested, and we investigated the effect ofunsaturated fatty acid in PtdEtn/PtdCho vesicles on the cofactor activity of thrombomodulin and on the interactions between thrombomodulin, thrombin and Protein C. It is proposed that a loss of preferential distribution of PtdEtn on the inside of the endothelial plasma membrane and its appearance on the outside of the membrane may modulate the cofactor activity of thrombomodulin. and 20) were prepared and labelled with horseradish peroxidase (HRP) as reported previously [22] . Mouse monoclonal anti-(human Protein C) IgG (PCmAb 7) which binds to the heavy chain of Protein C, recognizing the conformational structure of Protein C, was prepared in the same way as the TMmAbs.
EXPERIMENTAL
PurMcation of thrombomodulin from human placenta Thrombomodulin was purified from human placenta as described by Salem et al. [23] with some modifications. Briefly, thrombomodulin extracted from the tissue by treatment with 0.5 % Lubrol PX was subjected to column chromatography on DEAEcellulose, di-isopropylphospho-thrombin agarose and polyclonal antibody-coupled Sepharose 4B. Protein purity was examined by SDS/PAGE followed by staining with Coomassie Brilliant Blue. The purified thrombomodulin prepared from human placenta had a molecular mass of 105 kDa and was more than 900 pure as evaluated with a flying spot scanner SC-6000 (Shimadzu Co., Tokyo, Japan).
Recombinant thrombomodulin
Recombinant (r-) thrombomodulin was a gift from the Research Institute, Daiichi Pharmaceutical Co. It was expressed by introduction of pRS7TM into CHO-KI cells, and the secreted thrombomodulin was purified from the culture medium by chromatography on Q-Sepharose Fast Flow (Pharmacia-LKB) and anti-thrombomodulin monoclonal antibody Cellulofine followed by Sephacryl S-300 columns as described by Nawa et al. [24] . This r-thrombomodulin contains 491 amino acids from Nterminal Ala-I to C-terminal Ala-491, and lacks the transmembrane and cytoplasmic domains of endogenous thrombomodulin. All of the potential N-and 0-glycosylation sites were the same as those of native thrombomodulin.
Culture of human endothelial cells
Endothelial cells were isolated from human umbilical cord veins by the method of Jaffe et al. [25] , and were cultured in 60 or 100 mm-diameter collagen-coated dishes containing culture medium consisting of DMEM supplemented with 20% (v/v) FCS, 20 ,ug of ECGS/ml, 100 units of heparin/ml and antibiotics (50 ,ug of streptomycin/ml, 50 ,tg of penicillin/ml) [10] . Confluent primary cultures were passaged and cultured under the same conditions to confluency and then seeded in collagen-coated or uncoated dishes. These cells were grown to confluence under 5 [26] . The residue was spotted on silica gel 60F-254 (Merck) and developed first with chloroform/methanol/ammonium hydroxide (65:25:4, by vol.), followed by chloroform/methanol/ammonium hydroxide (50:25:6, by vol.) [27] . For [30] . In order to avoid oxidation of the phospholipids, the method described by Freyssinet et al. [30] Freyssinet et al. [30] , approximately one-half of thrombomodulin molecules must be localized on the inner side of the vesicles, because double the cofactor activity of thrombomodulin was found in the vesicles after treatment of the vesicles with 1 % Triton X-100 (final concentration). Rabbit thrombomodulin was reconstituted into phospholipid vesicles by the same method.
Sucrose-density-gradient centrifugation and measurement of thrombomodulin antigen
Thrombomodulin reconstituted into phospholipid vesicles (150 ,ul; phospholipid-to-thrombomodulin molar ratio 316500: 1) was layered on a discontinuous sucrose gradient [30, 25, 20, 15, 10 , 50% (w/w) in 0.15 M NaCl/20 mM Tris/HCl, pH 7.5, 2.5 ml each in order from the bottom] and centrifuged in a Hitachi swinging rotor (RPS-28-A1) for 16 h at 120000 g. Fractions of 1 ml each were obtained from the bottom with a peristaltic pump and then the amount of thrombomodulin antigen and the phospholipid content were measured. The total thrombomodulin antigen level was determined by using horseradish peroxidase (HRP)-labelled monoclonal antibodies against thrombomodulin (TMmAb2 and 11) as described previously [22] after treatment of fractions with 1 % Triton X-100 for 30 min at room temperature. More than 800% of thrombomodulin was recovered in the 0-150% sucrose fraction of the gradient when thrombomodulin was reconstituted into phospholipid vesicles, whereas less than 20% was recovered in that fraction in the absence of phospholipid.
Determination of cofactor activity of thrombomodulin The ability of thrombomodulin to accelerate thrombin-dependent Protein C activation was determined by the method of Tsiang et al. [31] with slight modifications. In short, thrombomodulin reconstituted into phospholipid vesicles was incubated in a medium containing 20 nM thrombin, 2 mM CaCl2, 2 1sM human Protein C/ml, 5 mg of BSA/ml and 0.15 M NaCl in 20 mM Tris/HCl (pH 7.4). Incubation was performed at 37 'C for 30 min and then thrombin was inactivated by the addition of a mixture of antithrombin III (final concentration 2 units/ml) and heparin (final concentration 8 units/ml). Boc-Leu-Ser-ThrArg-MCA, a synthetic substrate of activated Protein C, was added to the mixture and incubated for 10 min at 37 'C. After was measured by using a Hitachi spectrofluorimeter with excitation at 380 nm and emission at 440 nm, and the amount of activated Protein C was calculated from the activity of pure activated Protein C.
Preparation of y-glutamic acid (Gla)-domainless Protein C Gla-domainless Protein C was prepared by incubation of Protein C with chymotrypsin (at an enzyme/Protein C ratio of 1:400, w/w) for 30 min at 37 'C in 20 mM Tris/HCl (pH 7.4) containing 0.1 M NaCl [32] . After inactivation of the enzyme with diisopropyl fluorophosphate, the mixture was applied to a QAESephadex A-50 column as described by Esmon et al. [32] . The protein fraction eluted with an NaCl gradient was dialysed and concentrated with a Centricon-30 membrane (Amicon). The purity of Gla-domainless Protein C in each fraction was determined by gel electrophoresis on 10 % acrylamide. The purity of the final sample was more than 92 % in terms of the intensity of Coomassie Brilliant Blue staining. were comparable with those of other eukaryotes, with some exceptions [35, 36] . The specificity of phospholipid classes which could accelerate the cofactor activity of thrombomodulin for thrombin-dependent Protein C activation was investigated by measuring the amidolytic activity of activated Protein C (Table  2) . Phospholipids extracted from HUVECs were used after separation into phospholipid classes. Phospholipid vesicles were prepared at a 1: 1 (w/w) ratio of each phospholipid to PtdCho to avoid artificial effects of vesicle construction on thrombomodulin cofactor activity. Thrombomodulin reconstituted into phospholipid vesicles consisting of PtdCho alone or Ptdlns plus PtdCho (Ptdlns/PtdCho) increased the cofactor activity by 1.2-and 1.9-fold over the control respectively at a concentration of 0.5 mg of total phospholipid/ml of reaction mixture. On the other hand, 0.5 mg/ml of PtdSer/PtdCho and PtdEtn/PtdCho vesicles markedly increased the activity 4.3-and 8.4-fold respectively over that in the absence of phospholipid. These increases in activity were dependent on the concentration of PtdEtn or PtdSer up to 0.25 mg/ml (total 0.5 mg/ml). When rabbit lung thrombomodulin was used instead of that from human placenta, almost the same behaviour with respect to the phospholipid composition was observed (results not shown). The increase in activity was completely blocked when thrombomodulin was preincubated with anti-thrombomodulin IgG before reconstitution into the vesicles. These phospholipids did not directly affect either Protein C activation or the proteolytic activity of activated Protein C, as Protein C or activated Protein C mixed with the vesicles consisting of the respective phospholipid had the same activity as those without phospholipid (results not shown). These results indicate that PtdSer and PtdEtn greatly increase the cofactor activity of thrombomodulin for thrombin-dependent Protein C activation.
PtdEtn containing unsaturated fatty acid augments cofactor activity of thrombomodulin for thrombin-dependent Protein C activation The effect of the fatty acid composition of the phospholipid on the cofactor activity of thrombomodulin was studied (Figure 1 ). Authentic phospholipids containing stearic acid, linoleic acid and linolenic acid at the C-l and C-2 positions of the sn-glycerol moiety were used. When thrombomodulin was reconstituted into distearoyl (18: 0-18:0) PtdCho vesicles, no significant change in cofactor activity was observed compared with the control, which contained no phospholipids in the reaction mixture. An increase in degree of unsaturation of the fatty acid in PtdCho produced a slight increase in cofactor activity, i.e. the activity of thrombomodulin reconstituted into dioleoyl Thrombomodulin purified from human placenta was reconstituted into phospholipid vesicles consisting of authentic PtdEtn and PtdCho containing stearic acid, linoleic acid or linolenic acid at both the C-1 and C-2 positions of the sn-glycerol moiety. The assay conditions were as described in Figure 4 Protein C or Gla-domainiess Protein C activation by thrombinthrombomodulin or thrombin-transmembrane-domainless thrombomodulin complexes (a) Native thrombomodulin or r-thrombomodulin was suspended in buffer A containing 18:3-18:3 PtdEtn/18:0-18:0 PtdCho (0.25 mg plus 0.25 mg/ml) vesicles for more than 30 min at 20-25°C and Protein C activation was measured or (b) native thrombomodulin was suspended in buffer A containing the phospholipid vesicles and Protein C or Gla-domainless Protein C activation was measured. r-Thrombomodulin (491 amino acids) lacks both the transmembrane and cytoplasmic domains of endogenous thrombomodulin (557 amino acids). Gla-domainless Protein C was prepared by proteolytic removal of 41 amino acids from the Nterminus of the light chain of human Protein C (405 amino acids). The assay conditions were the same as those described in Table 2 . (a) Protein C activation by native thrombomodulin (-) and transmembrane-domainless thrombomodulin (0); (b) activation of Protein C (0) and Gla-domainless Protein C (0) by native thrombomodulin. modulin reconstituted into 18:3-18:3 PtdEtn/ 18: 0-18:0 PtdCho (Figure 3) . The Ca2l-dependence of the Protein-C activation system showed a hyperbolic curve in the absence of phospholipid, whereas it was sigmoidal in the presence of phospholipid vesicles and the activity was highest at the physiological concentration of serum Ca2+ (2-3 mM). The Ca2+-dependence of Gla-domainless Protein C activation fitted a simple hyperbolic curve irrespective of the presence of vesicles. The results in Figures 2 and 3 and Table 3 indicate that PtdEtn containing unsaturated fatty acid accelerates interactions between thrombin, thrombomodulin and Protein C in the presence of the plasma level of Ca2 .
In order to elucidate the mechanisms of increase in thrombindependent Protein C activation by thrombomodulin reconstituted into 18: 3-18: 3 PtdEtn/ 18: 0-18:0 PtdCho, cofactor activity was investigated by using r-thrombomodulin lacking both transmembrane domain and cytosolic domain compared with native thrombomodulin or Gla-domainless Protein C (Figure 4) . The increase in cofactor activity in 18:3-18:3 PtdEtn/18:0-18:0 PtdCho vesicles was completely abolished when r-thrombomodulin was used instead of native thrombomodulin (Figure 4a ) or when Gla-domainless Protein C was used instead of native Protein C (Figure 4b ). These results not only support the previous finding that interaction between the transmembrane domain of thrombomodulin and phospholipid vesicle is essential for the enhancement of cofactor activity [37] , but also indicate that the Gla-domain of Protein C plays a key role in the PtdEtn-dependent augmentation of cofactor activity.
In order to examine the binding efficacies of native Protein C and Gla-domainless Protein C on PtdEtn/PtdCho, vesicles of phospholipid with different degrees of unsaturation of the fatty acid were fixed on a microwell plate and the amount of Protein C or Gla-domainless Protein C bound to each phospholipid was determined. In the absence of Ca2+, native Protein C scarcely bound to PtdEtn regardless of the degree of unsaturation ( Figure  5a ). No function of thrombomodulin concentration was studied using the same procedure as for Protein C (Figure 5b ). Thrombomodulin binding to each phospholipid vesicle increased with the increase in protein concentration, and proportional increases in binding were observed in the range 1-5 nM thrombomodulin. The affinity between thrombomodulin and phospholipid is also reflected by the slope. With the increase in the degree of unsaturation of the fatty acid in PtdEtn, the slope increased irrespective of the absence of 2 mM Ca2+. [4] [5] [6] [7] . Studies on the environment of thrombomodulin on the surface of the plasma membrane are important in view of the physiological function of the molecule.
In the present study, we investigated the effects of phospholipid classes and fatty acid composition on thrombin-dependent Protein C activation by thrombomodulin (cofactor activity of thrombomodulin). We found that thrombin-thrombomodulincatalysed activation of Protein C was 8.4-fold higher in vesicles containing PtdEtn/PtdCho extracted from HUVECs than in the absence of phospholipid. The largest increase in cofactor activity of thrombomodulin by phospholipid (PtdSer/PtdCho) vesicles previously reported was 3-fold [13] . Therefore we focused on the effect of fatty acid composition of phospholipid on cofactor activity of thrombomodulin using PtdEtn. The ratio of PtdEtn/PtdCho (10-50 ,ug of phospholipid/reaction mixture) to thrombomodulin (15 ng/reaction mixture) used in this series of experiments for measuring cofactor activity is comparable with that found in the HUVECs, as we [10] and Bartha et al. [39] lipids in the plasma membrane [40, 41] , the decrease in the dissociation constant might arise from a conformational change in thrombomodulin on interaction of its transmembrane domain with PtdEtn/PtdCho. In our experiment, PtdEtn/PtdCho did not directly affect the proteolytic activity of thrombin (results not shown). It has been shown that the insertion of a cis double bond at the 9,10 position of saturated fatty acid at the sn-2 position of pure phospholipids causes striking alterations, which arise because the double bond makes an angle of 7-8°to the normal bilayer [42, 43] . As an ethanolamine residue is less bulky than a choline residue, a double bond in PtdEtn may allow a more flexible conformation of the hydrocarbon chains. Rothfield and Romeo [44] reported that the activity of certain membranebound enzymes depended critically on the presence of cis double bonds in phospholipid, indicating the existence of a specific interaction between enzymic recognition sites and the cis double bond. Therefore the activating role of the unsaturated fatty acid in phospholipid may depend on the unique configuration, and the cofactor activity of thrombomodulin may be controlled through modulation of the membrane fluidity.
The striking 18:3-18:3 PtdEtn-dependent increase in the affinity between thrombin-thrombomodulin complex and Protein C was reflected by a reduction in the Km value for Protein C to one-tenth of that in the presence of 18: 3-18: 3 PtdEtn/PtdCho vesicles. In the absence of phospholipid, thrombin-dependent Protein C activation and Gla-domainless Protein C activation by thrombomodulin were essentially the same (Figure 3 ). This result suggests that Protein C bound to thrombomodulin at some region other than the Gla domain and was activated by the thrombin-thrombomodulin complex. In the presence of 18:3-18:3 PtdEtn/18:0-18:0 PtdCho vesicles, on the other hand, thrombin-dependent Protein C activation caused by thrombomodulin was markedly elevated in a sigmoidal manner with respect to Ca2+ concentration, whereas the Gla-domainless Protein C activation showed a typical saturation curve with respect to Ca2+ concentration, and the activation was the same as that in the absence of phospholipid. This result indicates that the increase in cofactor activity of thrombomodulin reconstituted into phospholipid vesicles is related to the presence of the Gla domain in Protein C and the elevation effectively occurs at the plasma concentration of Ca2+. There are two inconsistent reports, one claiming that Protein C interacts directly with anionic phospholipids, leading to an increased affinity of Protein C for thrombin-thrombomodulin [19] and the other claiming that Protein C does not directly interact with phospholipids and binds to thrombomodulin that is conformationally changed by interaction with phospholipids [20, 45] . Our binding study ( Figure  5 ) shows that binding of Protein C to PtdEtn increased with an increase in degree of unsaturation of the fatty acid in the presence of Ca2+, although Gla-domainless Protein C did not bind to PtdEtn in the presence or absence of Ca2+. Therefore our results indicate that the Gla domain of Protein C interacts directly with PtdEtn in a Ca2+-dependent manner and facilitates the rapid activation of Protein C on phospholipid vesicles. We cannot exclude the possibility that the Gla domain of Protein C also recognizes thrombomodulin in a Ca2+-independent manner in addition to phospholipids on the membrane surface in a Ca2+_ dependent manner. Furthermore, the mechanism by which unsaturated fatty acid of PtdEtn increases the binding of Protein C to phospholipid vesicles is unknown.
It is generally accepted that mammalian plasma membranes display a stable asymmetrical distribution of lipids across the bilayer. Aminophospholipids PtdEtn and PtdSer are preferentially located at the cytoplasmic surface of various plasma localized in the inner membrane of HUVECs in our experiment, an increase in surface exposure of PtdEtn after thrombin treatment was observed. In platelets, transbilayer asymmetry is rapidly lost on activation by certain platelet agonists [46] [47] [48] [49] . Bevers et al. [48] demonstrated that stimulation of platelets with the Ca2+ ionophore A23187 or the combined action of collagen plus thrombin resulted in a rapid outer-surface appearance of PtdSer, which was almost entirely located on the cytoplasmic side of the plasma membrane of non-activated human platelets.
On the surface of endothelial cells, the rate of thrombin formation by the enzyme complex, Factor Xa-Factor Va, is also essentially dependent on the presence of an anionic phospholipid-containing surface [40] . In this respect, both pro-and anti-coagulation activities would be accelerated after exposure of PtdEtn and PtdSer at the surface of the plasma membrane. The present results indicate that partial loss of the asymmetric orientation of PtdEtn occurs in stimulated endothelial cells and this leads to the formation of an anticoagulant surface on the plasma membrane of endothelial cells, although the balance between pro-and anticoagulation on the membrane surface must be essentially dependent on the expression of the factors relating to pro-and anticoagulation [11] . On the basis of the topological data presented here and the fact that endothelial plasma membrane contains a large amount of unsaturated phospholipids (e.g. arachidonic acid is predominant at the C-2 position of PtdEtn) [21, 50] , it is reasonable to conclude that both the composition and distribution of phospholipids in the membrane modulate the proand anti-thrombotic state.
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